Literature DB >> 23382224

Computational modeling and experimental validation of the Legionella and Coxiella virulence-related type-IVB secretion signal.

Ziv Lifshitz1, David Burstein, Michael Peeri, Tal Zusman, Kierstyn Schwartz, Howard A Shuman, Tal Pupko, Gil Segal.   

Abstract

Legionella and Coxiella are intracellular pathogens that use the virulence-related Icm/Dot type-IVB secretion system to translocate effector proteins into host cells during infection. These effectors were previously shown to contain a C-terminal secretion signal required for their translocation. In this research, we implemented a hidden semi-Markov model to characterize the amino acid composition of the signal, thus providing a comprehensive computational model for the secretion signal. This model accounts for dependencies among sites and captures spatial variation in amino acid composition along the secretion signal. To validate our model, we predicted and synthetically constructed an optimal secretion signal whose sequence is different from that of any known effector. We show that this signal efficiently translocates into host cells in an Icm/Dot-dependent manner. Additionally, we predicted in silico and experimentally examined the effects of mutations in the secretion signal, which provided innovative insights into its characteristics. Some effectors were found to lack a strong secretion signal according to our model. We demonstrated that these effectors were highly dependent on the IcmS-IcmW chaperons for their translocation, unlike effectors that harbor a strong secretion signal. Furthermore, our model is innovative because it enables searching ORFs for secretion signals on a genomic scale, which led to the identification and experimental validation of 20 effectors from Legionella pneumophila, Legionella longbeachae, and Coxiella burnetii. Our combined computational and experimental methodology is general and can be applied to the identification of a wide spectrum of protein features that lack sequence conservation but have similar amino acid characteristics.

Entities:  

Mesh:

Year:  2013        PMID: 23382224      PMCID: PMC3581968          DOI: 10.1073/pnas.1215278110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Legionella tunisiensis sp. nov. and Legionella massiliensis sp. nov., isolated from environmental water samples.

Authors:  Angélique Campocasso; Mondher Boughalmi; Ghislain Fournous; Didier Raoult; Bernard La Scola
Journal:  Int J Syst Evol Microbiol       Date:  2012-02-03       Impact factor: 2.747

Review 2.  Q fever.

Authors:  Sally J Cutler; Maha Bouzid; Ronald R Cutler
Journal:  J Infect       Date:  2006-12-04       Impact factor: 6.072

3.  The complete genome sequence of Escherichia coli K-12.

Authors:  F R Blattner; G Plunkett; C A Bloch; N T Perna; V Burland; M Riley; J Collado-Vides; J D Glasner; C K Rode; G F Mayhew; J Gregor; N W Davis; H A Kirkpatrick; M A Goeden; D J Rose; B Mau; Y Shao
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

4.  Virulence factors encoded by Legionella longbeachae identified on the basis of the genome sequence analysis of clinical isolate D-4968.

Authors:  Natalia A Kozak; Meghan Buss; Claressa E Lucas; Michael Frace; Dhwani Govil; Tatiana Travis; Melissa Olsen-Rasmussen; Robert F Benson; Barry S Fields
Journal:  J Bacteriol       Date:  2009-12-11       Impact factor: 3.490

Review 5.  Coxiella type IV secretion and cellular microbiology.

Authors:  Daniel E Voth; Robert A Heinzen
Journal:  Curr Opin Microbiol       Date:  2009-01-12       Impact factor: 7.934

Review 6.  Legionella and Legionnaires' disease: 25 years of investigation.

Authors:  Barry S Fields; Robert F Benson; Richard E Besser
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

7.  Evidence in the Legionella pneumophila genome for exploitation of host cell functions and high genome plasticity.

Authors:  Christel Cazalet; Christophe Rusniok; Holger Brüggemann; Nora Zidane; Arnaud Magnier; Laurence Ma; Magalie Tichit; Sophie Jarraud; Christiane Bouchier; François Vandenesch; Frank Kunst; Jérôme Etienne; Philippe Glaser; Carmen Buchrieser
Journal:  Nat Genet       Date:  2004-10-03       Impact factor: 38.330

8.  A Legionella effector acquired from protozoa is involved in sphingolipids metabolism and is targeted to the host cell mitochondria.

Authors:  Elena Degtyar; Tal Zusman; Marcelo Ehrlich; Gil Segal
Journal:  Cell Microbiol       Date:  2009-04-27       Impact factor: 3.715

9.  The Coxiella burnetii ankyrin repeat domain-containing protein family is heterogeneous, with C-terminal truncations that influence Dot/Icm-mediated secretion.

Authors:  Daniel E Voth; Dale Howe; Paul A Beare; Joseph P Vogel; Nathan Unsworth; James E Samuel; Robert A Heinzen
Journal:  J Bacteriol       Date:  2009-05-01       Impact factor: 3.490

10.  Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages.

Authors:  Paul A Beare; Stacey D Gilk; Charles L Larson; Joshua Hill; Christopher M Stead; Anders Omsland; Diane C Cockrell; Dale Howe; Daniel E Voth; Robert A Heinzen
Journal:  mBio       Date:  2011-09-01       Impact factor: 7.867

View more
  88 in total

1.  Life Stage-specific Proteomes of Legionella pneumophila Reveal a Highly Differential Abundance of Virulence-associated Dot/Icm effectors.

Authors:  Philipp Aurass; Thomas Gerlach; Dörte Becher; Birgit Voigt; Susanne Karste; Jörg Bernhardt; Katharina Riedel; Michael Hecker; Antje Flieger
Journal:  Mol Cell Proteomics       Date:  2015-11-06       Impact factor: 5.911

2.  Legionella effectors reflect strength in diversity.

Authors:  Iñaki Comas
Journal:  Nat Genet       Date:  2016-02       Impact factor: 38.330

3.  Genomic analysis of 38 Legionella species identifies large and diverse effector repertoires.

Authors:  David Burstein; Francisco Amaro; Tal Zusman; Ziv Lifshitz; Ofir Cohen; Jack A Gilbert; Tal Pupko; Howard A Shuman; Gil Segal
Journal:  Nat Genet       Date:  2016-01-11       Impact factor: 38.330

4.  Study of Legionella Effector Domains Revealed Novel and Prevalent Phosphatidylinositol 3-Phosphate Binding Domains.

Authors:  Nimrod Nachmias; Tal Zusman; Gil Segal
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

5.  Architecture of the type IV coupling protein complex of Legionella pneumophila.

Authors:  Mi-Jeong Kwak; J Dongun Kim; Hyunmin Kim; Cheolhee Kim; James W Bowman; Seonghoon Kim; Keehyoung Joo; Jooyoung Lee; Kyeong Sik Jin; Yeon-Gil Kim; Nam Ki Lee; Jae U Jung; Byung-Ha Oh
Journal:  Nat Microbiol       Date:  2017-07-17       Impact factor: 17.745

6.  Poison domains block transit of translocated substrates via the Legionella pneumophila Icm/Dot system.

Authors:  Whitney M Amyot; Dennise deJesus; Ralph R Isberg
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

7.  Accurate prediction of bacterial type IV secreted effectors using amino acid composition and PSSM profiles.

Authors:  Lingyun Zou; Chonghan Nan; Fuquan Hu
Journal:  Bioinformatics       Date:  2013-09-23       Impact factor: 6.937

8.  Identification of novel Coxiella burnetii Icm/Dot effectors and genetic analysis of their involvement in modulating a mitogen-activated protein kinase pathway.

Authors:  Ziv Lifshitz; David Burstein; Kierstyn Schwartz; Howard A Shuman; Tal Pupko; Gil Segal
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

9.  The Legionella longbeachae Icm/Dot substrate SidC selectively binds phosphatidylinositol 4-phosphate with nanomolar affinity and promotes pathogen vacuole-endoplasmic reticulum interactions.

Authors:  Stephanie Dolinsky; Ina Haneburger; Adam Cichy; Mandy Hannemann; Aymelt Itzen; Hubert Hilbi
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

10.  Beyond Rab GTPases Legionella activates the small GTPase Ran to promote microtubule polymerization, pathogen vacuole motility, and infection.

Authors:  Hubert Hilbi; Eva Rothmeier; Christine Hoffmann; Christopher F Harrison
Journal:  Small GTPases       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.